OPC Pharmaceutical JSC Balance Sheet

Financials in millions VND. Fiscal year is January - December.

Millions VND. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	222,426	175,594	294,274	86,591	199,564
Short-Term Investments	95,900	71,624	27,018	69,345	18,516
Trading Asset Securities	68.95	68.95	68.95	159,269	68.95
Cash & Short-Term Investments	318,395	247,287	321,361	315,205	218,148
Cash Growth	28.75%	-23.05%	1.95%	44.49%	142.82%
Accounts Receivable	324,929	250,721	219,136	162,534	126,704
Other Receivables	-27,961	3,040	1,163	2,757	782.12
Receivables	296,968	253,762	220,299	165,291	127,486
Inventory	410,293	383,110	358,590	410,551	522,621
Prepaid Expenses	1,997	1,126	1,029	555.45	380.34
Other Current Assets	23,762	18,550	26,391	19,655	17,690
Total Current Assets	1,051,414	903,835	927,671	911,258	886,325
Property, Plant & Equipment	162,516	160,436	171,073	176,583	190,985
Long-Term Investments	21,285	24,996	24,385	24,203	23,688
Other Intangible Assets	72,793	73,945	73,928	75,031	76,131
Long-Term Deferred Tax Assets	6,064	4,559	9,523	3,155	3,305
Other Long-Term Assets	57,624	53,801	54,241	55,994	57,766
Total Assets	1,371,696	1,221,572	1,260,821	1,246,225	1,238,201
Accounts Payable	61,256	64,034	43,670	51,685	71,055
Accrued Expenses	115,626	50,417	82,895	92,016	93,386
Short-Term Debt	-	-	-	-	71,337
Current Income Taxes Payable	-	10,332	15,645	12,254	12,496
Current Unearned Revenue	-	-	3,262	28.45	186.75
Other Current Liabilities	209,863	215,185	226,274	212,853	241,172
Total Current Liabilities	386,745	339,969	371,747	368,836	489,633
Long-Term Unearned Revenue	5,000	-	-	-	-
Other Long-Term Liabilities	4,412	4,785	4,911	5,424	5,545
Total Liabilities	396,157	344,754	376,657	374,260	495,177
Common Stock	640,509	640,509	640,509	640,509	265,773
Additional Paid-In Capital	880.7	880.7	880.7	880.7	16,681
Retained Earnings	268,435	170,819	180,558	168,443	398,705
Comprehensive Income & Other	564.81	-	-	-	-
Total Common Equity	910,389	812,208	821,948	809,833	681,158
Minority Interest	65,150	64,610	62,216	62,131	61,865
Shareholders' Equity	975,539	876,818	884,164	871,964	743,023
Total Liabilities & Equity	1,371,696	1,221,572	1,260,821	1,246,225	1,238,201
Total Debt	-	-	-	-	71,337
Net Cash (Debt)	318,395	247,287	321,361	315,205	146,811
Net Cash Growth	28.75%	-23.05%	1.95%	114.70%	1007.84%
Net Cash Per Share	4970.97	3860.79	5017.28	4921.17	2292.11
Filing Date Shares Outstanding	64.05	64.05	64.05	64.05	64.05
Total Common Shares Outstanding	64.05	64.05	64.05	64.05	64.05
Working Capital	664,668	563,866	555,924	542,422	396,693
Book Value Per Share	14213.53	12680.67	12832.73	12643.58	10634.58
Tangible Book Value	837,596	738,264	748,020	734,802	605,027
Tangible Book Value Per Share	13077.04	11526.20	11678.52	11472.15	9445.99
Buildings	-	301,197	298,115	294,247	292,887
Machinery	-	259,564	259,681	251,688	249,240
Construction In Progress	37,170	24,288	21,639	17,079	14,351

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.